| CXSL1700157 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(1) | New Drug Application | 2018-04-04 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1700159 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(7) | New Drug Application | 2018-04-04 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1700158 | 重组胰高血糖素样肽-1-Fc融合蛋白注射液 | SAL-015 | Injection | Biological Products(7) | New Drug Application | 2018-04-04 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-10-08 | view |
| CXSL1600132 | 重组人促卵泡激素-CTP融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2017-04-27 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-06-08 | view |
| CXSL1600133 | 重组人促卵泡激素-CTP融合蛋白注射液 | | Injection | Biological Products(7) | New Drug Application | 2017-04-27 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2018-06-08 | view |
| CXSL1500121 | 注射用重组人甲状旁腺素(1-34)[56.5μg] | parathyroid hormone | Lyophilized | Biological Products(7) | New Drug Application | 2016-07-11 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2017-02-21 | view |
| CXSL1300095 | 重组抗CD20单克隆抗体注射液 | Recombinant anti-CD20 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2013-12-27 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2016-12-30 | view |
| CXSL1300094 | 重组抗CD20单克隆抗体注射液 | Recombinant anti-CD20 humanized monoclonal antibody | Injection | Biological Products(2) | New Drug Application | 2013-12-27 | 成都金凯生物技术有限公司 | Chengdu Jinkai Biotech Co Ltd | Certificate Issued | 2016-12-30 | view |
